责任编辑：韦子蓉 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 2026年1月8日，上海久诚律师事务所股票索赔许峰收到法院送达的普利制药（300630）上诉状，普利制 药对投资者胜诉提起上诉。前期许峰律师代理的普利制药投资者索赔案收到海口市中级人民法院一审判 决，投资者获得一审胜诉。律师团队同步还在继续推进后续案件的立案工作，还在继续接受其他投资者 的索赔委托。（许峰律师专栏） 2025年3月21日，普利制药公告公司于2025年1月4日收到证监会下发的《行政处罚决定书》。经查明， 2021年至2022年，普利制药通过虚构成品药和原料药销售业务的方式，虚假确认药品销售收入和利润。 其中，2021年多计营业收入436，606，838.34元，占当年披露营业收入的28.94%，对应营业成本128， 588，402.85元，多计利润总额308，018，435.49元，占当年披露利润总额的65.88%；2022年多计营业 收入456，639，341.72元 ...

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 根据最高人民法院虚假陈述司法解释，上市公司等因证券虚假陈述行为导致投资者权益受损，投资者可 以依法起诉索赔，索赔范围包括投资差额损失、佣金和印花税损失。 "上市公司退市，不影响投资者索赔资格。"厉健律师表示，根据司法解释，暂定：在2022年4月26日到 2024年4月16日期间买入普利制药股票，并且在2024年4月16日收盘还持有该股票的的受损股民，可索 赔。索赔条件以法院认定为准。 投资者索赔需提供证券开户信息查询单、股票对账单（2022年4月1日至今）、联系方式等。 【本文由浙江裕丰律师事务所厉健律师供稿，不代表新浪财经的立场。厉健律师，系中国法学会证券法 学研究会理事、中国证券业协会证券纠纷调解员，2009年荣获"浙江省优秀青年律师"称号。2003年至 今，厉健律师代理投资者告赢五粮液、大智慧等130余家上市公司并获赔，成效显著。其中，祥源文 化、赵薇案入选2019年度人民法院十大商事案例， ...

Core Viewpoint - Anqihome (600298) announced the convening of its fifth extraordinary shareholders' meeting on December 31, 2025, to discuss several key proposals related to its manufacturing projects [1] Group 1 - The shareholders' meeting will take place at 14:00 in the company's first-floor conference room [1] - The agenda includes the proposal for the implementation of the yeast extract compound intelligent manufacturing project at the Liuzhou company [1] - Another proposal on the agenda is for the annual production of 60,000 tons of flexible intelligent manufacturing and supporting projects for food raw materials at the park factory [1]

Group 1 - The company announced three capacity expansion plans with a total investment exceeding 1.5 billion RMB to enhance competitiveness and ensure supply of yeast products [1] - The Russian subsidiary plans to increase registered capital and implement a production line expansion project with an annual capacity of 22,000 tons of yeast, with a total investment of 1.062 billion RMB [1] - The company aims to achieve over 600,000 tons of total production capacity in the future, positioning itself as the world's largest yeast company [2][3] Group 2 - As of the first three quarters of this year, the company's revenue reached 11.786 billion RMB, representing a year-on-year growth of 8.01% [2] - The company has a domestic capacity utilization rate of over 90% and an overseas utilization rate of 100%, indicating a capacity shortfall [2] - The yeast industry is characterized by significant economies of scale, with high capacity utilization being crucial for maintaining gross margins [3]

Core Viewpoint - Angel Yeast is investing over 1.5 billion RMB in three capacity expansion projects to enhance its product competitiveness and ensure the supply of yeast and food raw materials [2][3]. Group 1: Investment Plans - The company plans to increase the registered capital of its wholly-owned subsidiary in Russia to implement a yeast production line expansion project with an annual capacity of 22,000 tons, with a total investment of 1.062 billion RMB [2]. - A flexible intelligent manufacturing project for food raw materials with an annual capacity of 60,000 tons is planned, with an investment of 215 million RMB, expected to start in February 2026 [2]. - The company aims to enhance the competitiveness of its yeast extract products through a smart manufacturing project in Liuzhou, with an investment of 232 million RMB, expected to commence in March 2026 [2]. Group 2: Current Operations and Market Position - As of mid-2025, Angel Yeast operates 16 yeast factories globally, with a total yeast product capacity exceeding 450,000 tons, making it the second-largest yeast company in the world [3]. - The company aims for a revenue growth of over 10% in 2025, with a reported revenue of 11.786 billion RMB in the first three quarters of the year, reflecting an 8.01% year-on-year increase [3]. - The current domestic capacity utilization rate is over 90%, while overseas capacity utilization is at 100%, indicating a capacity shortfall based on future sales plans [3]. Group 3: Industry Context - The global yeast production capacity exceeds 2.1 million tons, with major players including Lesaffre, Angel, and AB Mauri, holding over 70% of the market share [5]. - The yeast industry is characterized by significant economies of scale, where fixed costs decrease substantially with increased production, making high capacity utilization crucial for maintaining profit margins [4]. - To achieve its goal of becoming the world's largest yeast company, Angel Yeast must proactively expand its production capacity to capture market share and avoid missing industry consolidation opportunities [5].

Core Viewpoint - Angel Yeast (600298.SH) announced an investment of 232 million yuan in a smart manufacturing project for yeast extract blends, aiming to enhance product competitiveness and align with the company's strategic planning for the 14th Five-Year Plan [1] Group 1 - The investment amount for the yeast extract blending project is 232 million yuan, with an expected return on investment of 9.23% [1] - The project is in line with the company's strategic direction and is expected to improve operational quality, enhance sustainable profitability, and strengthen overall competitiveness [1] - The implementation of this project is projected to promote stable development without harming the interests of the company and its shareholders [1]

Core Viewpoint - Angel Yeast (600298.SH) announced an investment of 232 million yuan to enhance the competitiveness of its yeast extract products through the implementation of an intelligent manufacturing project at its Liuzhou facility [1] Company Summary - The investment amount for the yeast extract compounding intelligent manufacturing project is 232 million yuan [1] Industry Summary - The project aims to improve the competitiveness of yeast extract products within the industry [1]

Core Viewpoint - Angel Yeast (600298.SH) announced an investment of 232 million yuan to enhance the competitiveness of its yeast extract products through the implementation of an intelligent manufacturing project at its Liuzhou facility [1] Group 1 - The investment amount for the yeast extract compound intelligent manufacturing project is 232 million yuan [1]

Core Insights - The low-temperature sausage market is experiencing significant growth due to rising consumer health awareness and demand for food safety and quality [1][3] - The market size for low-temperature meat products in China increased from 290.7 billion yuan in 2017 to 434.8 billion yuan in 2020, with a CAGR of 14.35%, and is projected to reach 708.64 billion yuan by 2027 [3] - Low-temperature sausages are gaining popularity, accounting for about one-third of the low-temperature meat market, driven by health trends and convenience [3] Group 1: Market Demand and Growth - The low-temperature meat products utilize pasteurization, preserving the natural structure and components of meat, making them easier to digest and retaining more nutrients [3] - The frozen sausage segment is leading the market with over 31% market share and significant year-on-year growth [3] - Factors such as increased health consciousness, faster lifestyles, and the rise of kitchen appliances like air fryers are contributing to the popularity of low-temperature sausages [3] Group 2: Product Innovation and Trends - Companies are focusing on product innovation to capture market share and meet diverse consumer needs [4] - Health attributes are becoming core selling points, emphasizing quality ingredients, fat-to-lean ratios, and clean labels [5] - There is a trend towards unique and adventurous flavors to cater to consumer demand for novelty, with brands introducing flavors like spicy crayfish and black truffle [6][7] Group 3: Flavor and Customization - Brands are exploring local and international flavors, creating products that resonate with regional tastes while being adaptable to global preferences [7] - The market is seeing a shift towards personalized nutrition solutions, with products targeting specific consumer needs such as high protein and low burden for fitness enthusiasts [8] Group 4: Ingredient Innovation - The use of Biospringer yeast extract is becoming a key solution in enhancing the health and flavor profile of meat products, allowing for reduced salt content while improving taste and texture [9] - Examples of yeast extract applications include enhancing the flavor of mini spicy sausages and smoked chicken breast products [10] - The low-temperature sausage market is rapidly evolving, with ongoing innovations aimed at meeting diverse consumer demands for both taste and health [10]

Core Viewpoint - Company Anqi Yeast (600298) is experiencing growth driven by overseas markets, while domestic demand remains constrained due to demographic factors. The company is focusing on expanding its production capacity overseas while maintaining strategic opportunities in the domestic market [1][2][3]. Domestic Demand - Domestic demand is expected to grow at a low single-digit rate this year, influenced by factors such as an aging population. However, specific segments like small-packaged yeast are seeing double-digit growth [2]. Overseas Growth - The company has maintained over 20% growth in overseas markets in recent years, with regions like the Middle East, Africa, Southeast Asia, and Central Asia showing particularly high growth rates [3]. Production Capacity Planning - Future production capacity will primarily focus on overseas regions due to better raw material availability and market proximity. The company recently acquired Shengtong Sugar Industry to ensure stable raw material supply and reduce production costs [5]. Cost Structure - The main production raw material is molasses, which has a cyclical price influenced by various factors. The company anticipates that molasses prices will remain low in the coming years. Additionally, the company has developed hydrolyzed sugar as a substitute for molasses, currently accounting for about 30% of its raw material usage [10][13]. Competitive Landscape - The yeast industry is characterized by stable operations, with the company facing competition primarily from a few overseas firms. The competitive landscape remains relatively stable [12]. Second Growth Curve - The company is developing its second major product line, yeast extract, which has seen gradual growth since the establishment of its first production line in 2000. Other areas like synthetic biology and yeast protein are also being developed steadily [14][15]. Financial Performance - For the first half of 2025, the company reported a main revenue of 7.899 billion yuan, a year-on-year increase of 10.1%. The net profit attributable to shareholders was 799 million yuan, up 15.66% year-on-year [20]. Future Projections - The company aims to achieve a minimum revenue growth target of 10% as part of its stock incentive plan for 2025. The third quarter's performance is expected to align with the overall annual forecast [17]. Taxation and Financial Management - The overall corporate income tax rate for overseas operations is higher than that in China, but the company benefits from export tax rebates for its products in Egypt [18]. The company has maintained an asset-liability ratio below 50% in recent years, with targets set for 2025 and 2026 not exceeding 53% and 55%, respectively [19]. Market Development - The company sees significant growth potential for yeast extract in developed markets like Europe and North America, while in developing countries, market development is still needed due to local consumption levels [20].